Mesenchymal cells for skeletal tissue engineering

Expert Opinion on Biological Therapy

Volumn 8, Issue 7, 2008, Pages 885-893

  Slater, Bethany J ^a   Kwan, Matthew D ^a   Gupta, Deepak M ^a   Panetta, Nicholas J ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose derived stromal cells; Bone marrow derived stromal cells; Bone morphogenic protein; Induced pluripotent stem cells; Mesenchymal stem cells; Periosteum derived osteoprogenitor cells; Skeletal tissue engineering

Indexed keywords

BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL THERAPY; HUMAN; MESENCHYME CELL; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; TISSUE ENGINEERING;

ADIPOSE TISSUE; ANIMALS; BONE AND BONES; BONE DISEASES; BONE REGENERATION; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELLS; MESODERM; OSTEOBLASTS; REGENERATION; SIGNAL TRANSDUCTION; STEM CELLS; STROMAL CELLS; TISSUE ENGINEERING;

EID: 47549116418     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.8.7.885     Document Type: Review

References (73)

1. HCUPnet. Healthcare Cost and Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality, 2006. Available from: http://hcupnet.ahrq. gov/ [Last accessed 2 May 2008]
2. Sawin PD, Traynelis VC, Menezes AH. A comparative analysis of fusion rates and donor-site morbidity for aurogeneic rib and iliac crest bone grafts in posterior cervical fusions. J Neurosurg 1998;88(2):255-65
3. Buttermann. Prospective nonrandomized comparison of an allograft with bone morphogenic protein versus an iliac-crest autograft in anterior cervical discectomy and fusion. Spine J 2008;8(3):426-35
4. Silber JS, Anderson DG, Daffner SD, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28(2):134-9
5. Lee KJH, Roper JG, Wang JC. Demineralized bone matrix and spinal arthrodesis. Spine J 2005;5(6 Suppl):217S-223S
6. Aho AJ, Ekfors T, Dean PB, et al. Incorporation and clinical results of large allografts of the extremities and pelvis. Clin Orthop Relat Res 1994;(307):200-13
7. Eppley BL, Pietrzak WS, Blanton MW. Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon. J Craniofac Surg 2005;16(6):981-9
8. Parikh SN. Bone graft substitutes: past, present, furure. J Postgrad Med 2002;48(2):142-8
9. Rah DK. Art of replacing craniofacial bone defects. Yonsei Med J 2000;41(6):756-65
10. Wan DC, Nacamuli RP, Longaker MT. Craniofacial bone tissue engineering. Denr Clin North Am 2006;50(2):175-90
11. Schantz J-T, Hutmacher DW, Lam CXF, et al. Repair of calvarial defects with customised tissue-engineered bone grafts II. Evaluation of cellular efficiency and efficacy in vivo. Tissue Eng 2003;9(Suppl 1):S127-39
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145-7
13. Buttery LD, Bourne S, Xynos JD, et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 2001;7(1):89-99
14. Tremoleda JL, Forsyth NR, Khan NS, et al. Bone tissue formation from human embryonic stem cells in vivo. Cloning Stem Cells 2008;10(1):119-32
15. Bahadur G. The moral status of the embryo: the human embryo in the UK Human Fertilisation and Embryology (Research Purposes) Regulation 2001 debate. Reprod Biomed Online 2003;7(1):12-6
16. Weissman IL. Stem cells-scientific, medical, and political issues. N Engl J Med 2002;346(20):1576-9
17. Lees JG, Lim SA, Croll T, et al. Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regenerative Med 2007;2(3):289-300
18. Grinnemo K-H, Sylvon C, Hovarta O, et al. Immunogenicity of human embryonic stem cells. Cell Tissue Res 2008; 331(1):67-78
19. Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006;24(2):221-9
20. Pittenger MF, MacKay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7 •• In this paper, the authors isolated human mesenchymal stem cells from bone marrow aspirates of over 350 donors and demonstrated their proliferative capabilities as well as their multilineage potential.
21. Liechty KW, MacKenzie TC, Shaaban AF, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6(11):1282-6
22. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418(6893):41-9
23. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7(2):211-28 •• In this paper, the authors first isolated and characterized a population of cells obtained from the stromal vascular compartment of adipose tissue, named processed lipoaspirate. They show that these cells were able to be maintained in vitro for extended periods and differentiated into apipogenic, chondrogenic, myogenic and osteogenic lineages when treated with the appropriate inducing factors.
24. Nakahara H, Bruder SP, Haynesworth SE, et al. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum. Bone 1990;11(3):181-8
25. Seale P, Asakura A, Rudnicki MA. The potential of muscle stem cells. Dev Cell 2001;1(3):333-42
26. Gronthos S, Brahim J, Li W, et al. Stem cell properties of human dental pulp stem cells. J Dent Res 2002;81(8):531-5
27. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6(2):230-47
28. Friedensrein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974;2(2):83-92
29. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13(1):81-8
30. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surge Am 1998;80(7):985-96
31. Ohgushi H, Goldberg VM, Caplan AI. Repair of bone defects with marrow cells and porous ceramic. Experiments in rats. Acta Orthop Scand 1989;60(3):334-9
32. Bruder SP, Kurth AA, Shea M, et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16(2):155-62
33. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344(5):385-6
34. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13(5):947-55
35. Devine SM. Mesenchymal stem cells: will they have a role in the clinic? J Cell Biochem Suppl 2002;38:73-9
36. Beyth S, Borovsky Z, Mevorach D, et al. Human mesenchymal stem cells alter antigen-presenting cell marurarion and induce T-cell unresponsiveness. Blood 2005;105(5):2214-9
37. Maitra B, Szekely E, Gjini K, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004;33(6):597-604
38. Quarto R, Thomas D, Liang CT. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995;56(2):123-9
39. Reyes M, Verfaillie CM. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann NY Acad Sci 2001;938:231-3; discussion 233-5
40. Nishida S, Endo N, Yamagiwa H, et al. Number of osreoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab 1999;17(3):171-7
41. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33(6):919-26
42. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82(4):583-90
43. Zuk PA, Zhu M, Ashjian R et al. Human adipose tissue is a source of mulriporent stem cells. Mol Biol Cell 2002;13(12):4279-95
44. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10(3-4):371-80
45. Lee JA, Parrett BM, Conejero JA, et al. Biological alchemy: engineering bone and far from far-derived stem cells. Ann Plast Surg 2003;50(6):610-7
46. Cowan CM, Shi Y-Y, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22(5):560-7 •• A proof of concept animal study that demonstrated the in vivo osteogenic potential of adipose-derived adult stromal cells. The authors found that these cells were capable of regenerating critical-sized calvarial defects in mice when seeded on apatite-coated polylactic co-glycolic acid (PLGA) scaffolds. Furthermore, they showed that the contribution of the implanted cells contributed 84-99% of the new bone formation as detected by chromosomal analysis.
47. Dudas JR, Marra KG, Cooper GM, et al. The osteogenic potential of adipose-derived stem cells for the repair of rabbit calvarial defects. Ann Plast Surg 2006;56(5):543-8
48. Yoon E, Dhar S, Chun DE, Gharibjanian NA, Evans GRD. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007;13(3):619-27
49. Cowan CM, Aalami OO, Shi Y-Y, et al. Bone morphogeneric protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 2005;11(3-4):645-58 •• A follow-up study in which the authors added recombinant bone morphogenetic protein 2 and retinoic acid for four weeks ex vivo in order to accelerate in vivo osteogenesis. Regeneration of calvarial defects occurred rapidly, after two weeks, along with osteoclast recruitment and bone resorption.
50. Wan DC, Shi Y-Y, Nacamuli RP, et al. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci USA 2006;103(33):12335-40 •• This study was conducted to investigate the biological and molecular mechanisms underlying osteogenic differentiation of mouse adipose-derived adult stromal cells. They found that retinoic acid was required as well as upregulation of BMP receptor isoform IB during osteogenesis.
51. Wan DC, Siedhoff MT, Kwan MD, et al. Refining retinoic acid stimulation for osteogenic differentiation of murine adipose-derived adult stromal cells. Tissue Eng 2007;13(7):1623-31 •• In this study, the authors investigated the effects of abbreviated retinoic acid on adult-derived stromal cells' osteogenic differentiation. They found that pre-incubation of the cells in monolayer for 15 days wirh retinoic acid led to accelerated bone formation without concomitant osteoclastic resorption.
52. Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 2006;12(6):1405-18
53. Deng Z-L, Sharff KA, Tang N, et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008;13:2001-21
54. Syftestad GT, Weitzhandler M, Caplan AI. Isolation and characterization of osteogenic cells derived from first bone of the embryonic tibia. Dev Biol 1985;110(2):275-83
55. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52(8):2521-9
56. Choi Y-S, Noh S-E, Lim S-M, et al. Multipotency and growth characteristic of periosteum-derived progenitor cells for chondrogenic, osteogenic, and adipogenic differentiation. Biotechnol Lett 2008;30(4):593-601
57. De Bari C, Dell'Accio F, Vanlauwe J, et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006;54(4):1209-21
58. Schmelzeisen R, Schimming R, Sittinger M. Soft tissue and hard tissue engineering in oral and maxillofacial surgery. Ann R Australas Coll Dent Surg 2002;16:50-3
59. BioTissue Technologies. Freiburg, Germany: BioTissue Technologies GmbH. Available from: www.biotissue.de [Last accessed 2 May 2008]
60. Horwitz EM, Gordon PL, Koo WKK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 2002;99(13):8932-7
61. Iso Y, Spees JL, Serrano C, et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 2007;354(3):700-6
62. Prockop DJ. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther 2007;82(3):241-3
63. Le Blanc K, Gotherstrom C, Ringden O, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005;79(11):1607-14
64. Kumar S, Ponnazhagan S. Bone homing of mesenchymal stem cells by ectopic α4 integrin expression. FASEB J 2007;21(14):3917-27
65. Zhang XS, Linkhart TA, Chen S-T, et al. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J Gene Med 2004;6(1):4-15
66. Spees JL, Olson SD, Whitney MJ, Prockop DJ. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 2006;103(5):1283-8
67. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24(5):1294-301
68. Asian H, Zilberman Y, Kandel L, et al. Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells. Stem Cells 2006;24(7):1728-37
69. Aluigi M, Fogli M, Curti A, et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24(2):454-61
70. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adulr human fibroblasts by defined factors. Cell 2007;131(5):861-72 • This study demonstrated successful generation of induced pluripotent stem cells from adult human dermal fibroblasts with four factors, octamer-binding transcription factor (Oct)3/4, sex determining region Y-box (Sox)2, kruppel-like factor (Klf)4, and cellular myelocytomatosis oncogene (c-Myc). This reprogramming of differentiated human somatic cells has the potential to create patient- and disease-specific stem cells.
71. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318(5858):1917-20 • The authors show that four factors (OCT4, SOX2, NANOG, and Lineage family member (LIN28) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem cells.
72. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008;26(1):101-6
73. Daley GQ, Scadden DT. Prospects for stem cell-based therapy. Cell 2008;132(4):544-8